by Lisa Jarvis New data from an experimental drug being developed by Eli Lilly & Co. raises an intriguing question about obesity treatments: How low can the […]
Tag: Eli Lilly
The point where ethics and profits intersect
While the West Virginia Legislature debated making insulin more affordable, one pharmaceutical company surprisingly stepped up. On March 1, Eli Lilly announced it would limit monthly patient […]
